Zhu M - Search Results

1

Efficacy and Safety of Jiuxin Pill in the Treatment of Patients with Stable Angina Pectoris: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.

Liu T, Zhang J, Zhao Z, Bi Y, Zheng Y, Wang S, Dai X, Li J, Lin Q, Ni D, Wang C, Wu J, Xue Y, Zhu M, Wang X, Mao J. Liu T, et al. Among authors: zhu m. Int J Gen Med. 2024 Oct 15;17:4711-4722. doi: 10.2147/IJGM.S485329. eCollection 2024. Int J Gen Med. 2024. PMID: 39429963 Free PMC article.

2

Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.

Tian Y, Zhang J, Zhao Y, Mao J, Zhu L, Gao R, Wang X, Zhu M, Ma L, Zhao M, Zheng W. Tian Y, et al. Among authors: zhu l, zhu m. Trials. 2018 Oct 20;19(1):577. doi: 10.1186/s13063-018-2950-7. Trials. 2018. PMID: 30342551 Free PMC article.

3

Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial.

Mao J, Zhang J, Lam CSP, Zhu M, Yao C, Chen S, Liu Z, Wang F, Wang Y, Dai X, Niu T, An D, Miao Y, Xu T, Dong B, Ma X, Zhang F, Wang X, Fan R, Zhao Y, Jiang T, Zhang Y, Wang X, Hou Y, Zhao Z, Su Q, Zhang J, Wang B, Zhang B. Mao J, et al. Among authors: zhu m. ESC Heart Fail. 2020 Dec;7(6):3881-3890. doi: 10.1002/ehf2.12980. Epub 2020 Sep 21. ESC Heart Fail. 2020. PMID: 32954647 Free PMC article.

4

Evidence-based traditional Chinese medicine research: Beijing Declaration.

Zhang J, Li Y, Zhang B, Chen K, Wang Q, Li Z, Sun S, Tian J, Sun X, Yao C, Xie Y, Hu J, Tian J, Zhan S, Liu J, Wu J, Sun F, Du L, Yu J, Zhang Y, Zhang L, Gao R, Wang B, Tang J, Zhu M, Mao J, Huang Y, Zheng W, Yang F, Pang B; academic committee of Evidence-Based Chinese Medicine panel of the 12th Health China Forum. Zhang J, et al. Among authors: zhu m. J Evid Based Med. 2020 May;13(2):91-92. doi: 10.1111/jebm.12389. J Evid Based Med. 2020. PMID: 32470228 No abstract available.

5

Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials.

Wei J, Ma T, Zhou C, Hao P, Li B, Wang X, Yu R, Zhu M, Wang Y. Wei J, et al. Among authors: zhu m. Front Pharmacol. 2022 Nov 14;13:1002713. doi: 10.3389/fphar.2022.1002713. eCollection 2022. Front Pharmacol. 2022. PMID: 36452225 Free PMC article.

6

Systematic Evaluation of Clinical Efficacy and Platelet Function of Sofren Injection in the Treatment of Angina Pectoris.

Fan G, Liu M, Xing Z, Chen Z, Zhu M, Wang Y. Fan G, et al. Among authors: zhu m. Evid Based Complement Alternat Med. 2021 Mar 26;2021:5591137. doi: 10.1155/2021/5591137. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 33854555 Free PMC article. Review.

7

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis.

Zhu M, Wei J, Li Y, Wang Y, Ren J, Li B, Ma B, Wang X, Qiao L, Zhou C, Liu J. Zhu M, et al. Front Pharmacol. 2022 Mar 18;13:831208. doi: 10.3389/fphar.2022.831208. eCollection 2022. Front Pharmacol. 2022. PMID: 35370712 Free PMC article.

8

Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial.

Guo M, Wang P, Du J, Fu C, Yang Q, Gao Z, Zhu M, Lv S, Deng Y, Li T, Shi D, Working Group FTX. Guo M, et al. Among authors: zhu m. Pharmacol Res. 2020 Aug;158:104883. doi: 10.1016/j.phrs.2020.104883. Epub 2020 May 22. Pharmacol Res. 2020. PMID: 32446979 Clinical Trial.

9

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.

Wei J, Liu S, Wang X, Li B, Qiao L, Wang Y, Zhu M. Wei J, et al. Among authors: zhu m. Evid Based Complement Alternat Med. 2021 Dec 11;2021:2672516. doi: 10.1155/2021/2672516. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34931125 Free PMC article. Review.

10

Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial.

Wang Y, Wang X, Wang J, Li B, Yu R, Hu Y, Li X, Peng G, Zhang M, Zhu M. Wang Y, et al. Among authors: zhu m. Trials. 2020 Mar 20;21(1):287. doi: 10.1186/s13063-020-4208-4. Trials. 2020. PMID: 32197640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,833 results

Search Page

Filters